LZLiqing Zheng

Liqing Zheng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Liqing Zheng has a total of 23 co-authors. Here are the top co-authors by number of shared publications:

  • Jianhua Liu

    Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Hebei North University, Zhangjiakou 075000, Hebei Province, China

    2 shared publications
  • Lixia Shen

    Hebei North University

    2 shared publications
  • Ze Li

    Hebei Key Laboratory of Neuropharmacology, Department of Pharmacy, Hebei North University, Zhangjiakou 075000, Hebei Province, China

    2 shared publications
  • Haixia Qiao

    Hebei North University

    1 shared publication
  • Jianhua Liu

    Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Hebei North University, Zhangjiakou 075000, China

    1 shared publication
  • Jianhua Liu

    Hebei Key Laboratory of Pathogenic Mechanisms and Diagnosis & Treatment Technologies for Lung Microbiome, The First Affiliated Hospital of Hebei North University, China

    1 shared publication

Latest Publications

  • Open Access

    Design, Preparation, and Evaluation of Osthol Poly-Butyl-Cyanoacrylate Nanoparticles with Improved In Vitro Anticancer Activity in Neuroblastoma Treatment

    by Liqing Zheng, Lixia Shen, Ze Li, Xiaoli Zhang, Miaomiao Wu, Yuanyuan Zhang, Jianhua Liu

    Osthol (osthole), known as a neuroprotective drug, has shown potent anticancer activity. However, the potential clinical application of osthol is limited due to its low water solubility and low bioavailability. Polybutyl cyanoacrylate (PBCA) has been widely used to improve the solubility of drugs with poor water solubility. In this study, an orthogonal experimental design (OED) was applied to design the preparation process of PBCA nanoparticles (NPs). Then, nanoparticles were prepared and evaluated in terms of physicochemical properties, in vitro release, and cellular uptake, etc. Further, the anti-cancer activity of osthol-PBCA NPs was demonstrated in SH-SY5Y cells. The pharmacokinetics and area under the curve (AUC) were investigated. The obtained osthol-NPs presented a spherical shape with a particle size of 110 ± 6.7 nm, a polydispersity index (PDI) of 0.126, and a zeta potential of −13 ± 0.32 mV. Compared with the free osthol, the drugs in osthol-NPs presented better stability and sustained release pattern activity. In vitro analysis using SH-SY5Y neuroblastoma cells showed that osthol-loaded nanoparticles displayed a significantly enhanced intracellular absorption process (three times) and cytotoxicity compared with free osthol (p < 0.05, increased 10–20%). The in vivo pharmacokinetic study revealed that the AUC of osthol-NPs was 3.3-fold higher than that of free osthol. In conclusion, osthol-PBCA NPs can enhance the bioactivity of osthol, being proposed as a novel, promising vehicle for drug delivery.


  • Open Access

    The oxidation Stress, mitochondrial-pathway Apoptosis and the antagonism effects of chrysophanol in SH-SY5Y Cells via DTPP induced photodynamic therapy

    by Liqing Zheng, Zhao Wang, Ze Li, Jianhua Liu, Lixia Shen

    To investigate the susceptibility of SH-SY5Y cells to DTPP-based photodynamic therapy(PDT) and the interaction with chrysophanol. Cells were treated with increasing concentrations of DTPP between 2.5 to 20 μg·mL-1 and the DTPP -induced killing effects in tumor cells was quantified determined. PDT photocytotoxicity was measured by exposing the cells to a 630-nm irradiation for 1.2–9.6 J/cm2. The photodynamic stress was assessed by superoxide dismutase, malondialdehyde, and total antioxidative capacity assays. The apoptosis pathway of SH-SY5Y cells after PDT was studied by JC-1 and caspase-9/Caspase-3 determination. The cell apoptosis cells stained with Annexin-V-FITC and propidium iodide were detected through flow cytometry. In the PDT process, a dose-dependent killing effect of DTPP concentrations and irradiation doses were found. The viability of SH-SY5Y cells treated with 10 μg·mL-1 DTPP rapidly decreased to 55%. Cells apoptosis is mediated by a mitochondrial -pathway with a total apoptosis rate of 33.8% with 10 μg·mL-1 of DTPP after illumination at 2.4 J/cm2. Thus, our results demonstrated that an oxidation stress was produced by ROS in PDT and a non-reversible cells oxidative damage appeared via cells modulating the oxidative stress balance during the PDT response. Chr had an inhibitor effect on the capture of ROS and the destruction of cell membrane induced by PDT. In conclusion, neuroblastoma cell line SH-SY5Y cells were susceptible to DTPP-PDT, resulting in a mitochondrial apoptosis pathway. DTPP is a potential type I photosensitizers to revitalize photodynamic oncotherapy in SH-SY5Y cells. There is an antagonism effect of chrysophanol on PDT in SH-SY5Y neuroblastoma cells.

  • Effect of DTPP-mediated photodynamic therapy on cell morphology, viability, cell cycle, and cytotoxicity in a murine lung adenocarcinoma cell line

    by Jianhua Liu, Liqing Zheng, Yingxin Li, Zhihua Zhang, Li Zhang, Lixia Shen, Xiulong Zhang, Haixia Qiao

    Photodynamic therapy (PDT) involves the administration and activation of photosensitizing reagents in cancer tissues to induce cytotoxicity. Here we examined the effects of 5-5- (4-N, N-diacetoxylphenyl)-10,15,20- tetraphenylporphyrin (DTPP) -mediated PDT on cell morphology, viability, cell cycle, and cytotoxicity in a murine lung adenocarcinoma cell line. LA795 murine lung adenocarcinoma cell line was used in the study, with cellular uptake of DTPP being quantified by a UV-visible spectrophotometer. The subcellular localization of DTPP was detected by confocal laser scanning microscopy, alteration of cell morphology after PDT was observed by an inverted light microscope, and late-stage apoptosis was examined by terminal dUTP nick end labeling (TUNEL) . The effects of influencing factors on cytotoxicity of PDT in LA795 cells was investigated with varying concentrations of DTPP, energy densities, power densities, and antioxidants by 3- (4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays. Effects of PDT on cell cycle and plasma membrane integrity were studied by flow cytometry analysis. The uptake of DTPP by LA795 cells reached maximum after incubation for 24 h. Confocal laser scanning microscopy showed that DTPP was mainly in the mitochondrion, and slight localization was detected in the lysosomes. Cellular inhibitory effects increased with increased irradiation dose and DTPP concentration, while unactivated DTPP had low toxicity. Flow cytometry analysis revealed that DTPP-PDT-treated cells showed S phase arrest. Cell membrane damage initiation, repair, and irreversible damage were observed at 2, 4, and 5 h after DTPP-PDT , respectively. Together, our results demonstrated cell apoptosis, compromised viability, and cell cycle S phase arrest of LA795 in response to DTPP-PDT , while no effect on the lung cancer cells was observed with irradiation or photosensitizer treatment alone.